NCT03820583 is a NA clinical trial of Whipple Procedure in Whipple Procedure, sponsored by Services Hospital, Lahore.

Who is sponsoring NCT03820583?

NCT03820583 is sponsored by Services Hospital, Lahore.

What drugs are being tested in NCT03820583?

Interventions in NCT03820583: Whipple Procedure.

What condition does NCT03820583 study?

NCT03820583 studies Whipple Procedure.

Is NCT03820583 still recruiting?

NCT03820583 is currently completed. Last updated 31 January 2019.

Last reviewed 2019-01-31 · How we verify

NCT03820583

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Whipple Procedure: A 5-year Clinical Experience in Tertiary Care Center

Completed NA Last updated 31 January 2019

What this trial tests

NA trial testing Whipple Procedure in Whipple Procedure in 57 participants. Completed in 31 December 2018.

Timeline

1 January 2014

Primary endpoint
31 December 2018

31 December 2018

Quick facts

Lead sponsor	Services Hospital, Lahore
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	57
Start date	1 January 2014
Primary completion	31 December 2018
Estimated completion	31 December 2018
Sites	1 location across Pakistan

Drugs / interventions tested

Whipple Procedure

Conditions studied

Whipple Procedure — all drugs for Whipple Procedure →

Sponsor

Services Hospital, Lahore

Who can join

Adults 20 to 70, any sex, with Whipple Procedure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study was conducted in tertiary care hospital of Lahore. Patient undergoing Whipple procedure were studied by compiling demographic details of the patients, common presenting symptoms, various indications for Whipple's procedure, the cofactors which affect the procedures outcome and morbidity and mortality of the patients.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Whipple Procedure: A Five-Year Clinical Experience in Tertiary Care Center.
Changazi SH, Ahmed Q, Bhatti S, Siddique S, et al · · 2020 · cited 11× · PMID 33329963 · DOI 10.7759/cureus.11466

Verify or expand the search:

Other Services Hospital, Lahore trials

Trials by the same sponsor.

NCT06239207 — Efficacy and Safety of Exosomes Versus Platelet Rich Plasma in Patients of Androgenetic Alopecia · Phase 2 · completed
NCT07395388 — Intraoperative Methylene Blue Spray for the Identification and Preservation of Vital Structures in Thyroidectomy · NA · completed
NCT05714423 — Outcomes in Lower Pole Kidney Stone Management Using Mini-PCNL Compared With Retrograde Intra Renal Surgery · NA · completed
NCT07473388 — Clipless Versus Conventional Laparoscopic Cholecystectomy Using Harmonic Scalpel · NA · completed
NCT07493343 — EUSOL vs. PDGF Dressing for Diabetic Foot Ulcers · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03820583 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Services Hospital, Lahore
Last refreshed: 31 January 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03820583.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing